Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, today announced that it has delivered the first phase of its previously announced expansion program of approximately $180 million USD to meet growing customer capacity needs for injection system solutions .
BD Launches Plunger Stopper in Partnership with Aptar Pharma to Enhance Biologic Drug DeliveryFRANKLIN LAKES, N.J., October 13, 2021 / B3C newswire / BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD SCF™ PremiumCoat®&dagger.